Literature DB >> 16219518

Placental localization and expression of the cell death factors BNip3 and Nix in preeclampsia, intrauterine growth retardation and HELLP syndrome.

H Stepan1, C Leo, S Purz, M Höckel, L-C Horn.   

Abstract

OBJECTIVE: BNip3 and its homologue Nix are pro-apoptotic factors of the Bcl-2-family and are expressed in malignant tumors. In vitro, this expression was shown to be mediated by hypoxia. Recently, it has been shown that placental hypoxia as well as apoptosis are pathogenetic factors for pregnancy-induced hypertensive diseases and intrauterine growth retardation (IUGR). The aim of the study was to analyze placental expression of BNip3 and Nix in pregnancies complicated by preeclampsia, hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome and IUGR.
MATERIAL AND METHODS: Placental tissue was sampled from 10 pregnancies each with preeclampsia, HELLP syndrome, IUGR and gestational age-matched controls. The placental expression of BNip3/Nix has been investigated with immunohistochemistry by the use of specific human BNip3/Nix antibodies.
RESULTS: In cytotrophoblastic cells, the BNip3 expression was strong in the control placentas, but only mediate in the placentas from pregnancies with preeclampsia, IUGR or HELLP syndrome. The intensity of the Nix staining showed a similar pattern. In the syncytiotrophoblast, there was a weak BNip3 staining observable in the control as well as IUGR samples, whereas BNip3 was undetectable in preeclamptic placentas or those with HELLP syndrome. For Nix, only in the preeclampsia a weak staining was detectable, whereas all other probes were negative.
CONCLUSIONS: Our study shows for the first time that the pro-apoptotic proteins BNip3 and Nix are expressed in the human placenta. Pregnancies with placental dysfunction and hypertensive pregnancy disorders with different clinical manifestations are characterized by a significantly decreased expression of BNip3 and Nix. These results suggest that the hypothesis of generally increased placental apoptosis in pregnancy-induced hypertensive disorders caused by disturbed trophoblast invasion has to be partly reconsidered.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16219518     DOI: 10.1016/j.ejogrb.2005.01.017

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  6 in total

1.  Expression profile of C19MC microRNAs in placental tissue in pregnancy-related complications.

Authors:  Ilona Hromadnikova; Katerina Kotlabova; Marketa Ondrackova; Petra Pirkova; Andrea Kestlerova; Veronika Novotna; Lucie Hympanova; Ladislav Krofta
Journal:  DNA Cell Biol       Date:  2015-03-31       Impact factor: 3.311

2.  Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor alpha agonists.

Authors:  Lei Guo; Hong Fang; Jim Collins; Xiao-hui Fan; Stacey Dial; Alex Wong; Kshama Mehta; Ernice Blann; Leming Shi; Weida Tong; Yvonne P Dragan
Journal:  BMC Bioinformatics       Date:  2006-09-06       Impact factor: 3.169

3.  Maternal age effects on myometrial expression of contractile proteins, uterine gene expression, and contractile activity during labor in the rat.

Authors:  Matthew Elmes; Alexandra Szyszka; Caroline Pauliat; Bethan Clifford; Zoe Daniel; Zhangrui Cheng; Claire Wathes; Sarah McMullen
Journal:  Physiol Rep       Date:  2015-04

4.  Cumulative Antenatal Risk and Kindergarten Readiness in Preterm-Born Preschoolers.

Authors:  Andrew M Heitzer; Jamie C Piercy; Brittany N Peters; Allyssa M Mattes; Judith M Klarr; Beau Batton; Noa Ofen; Sarah Raz
Journal:  J Abnorm Child Psychol       Date:  2020-01

5.  Impaired placental mitophagy and oxidative stress are associated with dysregulated BNIP3 in preeclampsia.

Authors:  Xiaobo Zhou; Xue Zhao; Wei Zhou; Hongbo Qi; Hua Zhang; Ting-Li Han; Philip Baker
Journal:  Sci Rep       Date:  2021-10-14       Impact factor: 4.379

6.  Expression of BNIP3 in invasive breast cancer: correlations with the hypoxic response and clinicopathological features.

Authors:  Esther A Koop; Theo van Laar; Dick F van Wichen; Roel A de Weger; Elsken van der Wall; Paul J van Diest
Journal:  BMC Cancer       Date:  2009-06-09       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.